Cyclacel Pharmaceuticals, Inc. (CYCC) To Webcast Institutional Investor And Analyst Presentation On Clinical Development Plan Of Sapacitabine For MDS
5/28/2014 9:19:43 AM
BERKELEY HEIGHTS, N.J., May 28, 2014 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, today announced that it will webcast an invitation-only institutional investor and analyst presentation from 6:30 p.m. to 8 p.m. CDT, Saturday, May 31, in Chicago during the 2014 ASCO Annual Meeting.
Help employers find you! Check out all the jobs and post your resume.
comments powered by